News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Samer Al Hadidi: Bispecific Antibody Therapy in CNS Myeloma
Samer Al Hadidi/LinkedIn
Aug 28, 2025, 14:58

Samer Al Hadidi: Bispecific Antibody Therapy in CNS Myeloma

Samer Al Hadidi, Associate Professor at UAMS – University of Arkansas for Medical Sciences, shared a post on X:

“Check our recent work: Bispecific antibody therapy in CNS myeloma: Early evidence from a multicentre cohort

– 100% CNS response (n=6 evaluable)
– 2 pts responded before CNS-directed therapy
– No grade ≥3 CRS or ICANS.”

Bispecific antibody therapy

Title: Bispecific antibody therapy in CNS myeloma: Early evidence from a multicentre cohort

Authors: Alexandra Noveihed, Samer Al Hadidi, Meera Mohan, Mansi R. Shah

Read Full Article.

Bispecific antibody therapy

More posts featuring Samer Al Hadidi on OncoDaily.

Alexandra Noveihed cancer Mansi R. Shah Meera Mohan OncoDaily Oncology Samer Al Hadidi
Special Coverage
Science
Aug 28, 2025, 14:58
Samer Al Hadidi: Bispecific Antibody Therapy in CNS Myeloma
Oncolibrary
Aug 28, 2025, 14:51
Press Release: Verzenio (Abemaciclib) Increases Overall Survival in High-Risk HR+, HER2- Early BC.
Voices
Aug 28, 2025, 14:33
Nicolas Hart: Driving National Cancer Survivorship Advocacy with COSA
Insight
Aug 28, 2025, 14:22
Yüksel Ürün Highlights Ten-year Survival Rates of CHAARTED Trial
Insight
Aug 28, 2025, 14:13
Thomas Flaig Announces 2025 AB Nexus Grant Awardees
Insight
Aug 28, 2025, 14:03
Minhua Chu: Shenzhen Pregene Biopharma Received FDA Orphan Drug Designation
Science
Aug 28, 2025, 13:48
Hamza Hashmi Highlights Study on Immune-MRD and Myeloma Outcomes
Insight
Aug 28, 2025, 13:43
In Memoriam of Bonnie J. Addario։ A Legacy of Hope, Advocacy, and Change in Lung Cancer
OncoDaily Pulse
Aug 28, 2025, 13:40
10 Leading Experts Join OncoDaily Journal Editorial Team
Science
Aug 28, 2025, 13:36
Marios Georgakis on IL-6 Inhibition, Genetics as a Tool for Drug Validation
Insight
Aug 28, 2025, 13:30
Thaís Megid: Have You Ever Heard About Negative Hyperselection for EGFR Therapy?
Societies
Aug 28, 2025, 13:19
Breaking Barriers to Diagnostic Access - The Max Foundation